HLB Co., Ltd. (KOSDAQ:028300)
South Korea · Delayed Price · Currency is KRW 46,600
-950 (-2.00%)
Aug 6, 2025, 12:40 PM KST
Splunk Market Cap
HLB Co., Ltd. has a market cap or net worth of 6.24 trillion as of August 5, 2025. Its market cap has decreased by -48.19% in one year.
Market Cap
6.24T
Enterprise Value
6.39T
Revenue
74.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
$46,600.00
Market Cap Chart
Since December 24, 2008, HLB Co., Ltd.'s market cap has increased from 13.46B to 6.24T, an increase of 46,243.40%. That is a compound annual growth rate of 44.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 6,237.58B | -34.93% |
| Dec 30, 2024 | 9,585.71B | 46.53% |
| Dec 28, 2023 | 6,541.97B | 98.02% |
| Dec 29, 2022 | 3,303.67B | -10.84% |
| Dec 30, 2021 | 3,705.38B | -24.18% |
| Dec 30, 2020 | 4,887.34B | -0.25% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.59T |
| Celltrion | 37.76T |
| ALTEOGEN | 22.55T |
| Yuhan | 8,432.74B |
| SK Biopharmaceuticals | 7,345.78B |
| Peptron | 6,523.26B |
| PharmaResearch | 5,724.70B |
| LigaChem Biosciences | 4,611.27B |